Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation

Obeng, Esther A., Chappell, Ryan J., Seiler, Michael, Chen, Michelle C., Campagna, Dean R., Schmidt, Paul J., Schneider, Rebekka K., Lord, Allegra M. +12 more·2016·Cancer Cell
DOI 10.1016/j.ccell.2016.08.006

Cited by (380)

Items 301–380 of 380

  1. Elevated B12 serum levels are associated with the presence of clonal hematopoiesis
    Varun Gupta, Peter D. Lyon, Aristeidis G. Telonis, Marina Y Konopleva, Luisa Cimmino · 2025 · Blood Neoplasia
  2. MDS/MPN-RS-T justified inclusion as a unique disease entity?
    Guillermo Montalban Bravo, Guillermo Garcia‐Manero · 2020 · Best Practice & Research Clinical Haematology
  3. Transcriptional configurations of myeloproliferative neoplasms
    Fiorella Schischlik · 2022 · International review of cytology
  4. A Novel Prognostic Scoring Model for Myelodysplastic Syndrome Patients With SF3B1 Mutation
    Liya Ma, Bin Liang, Huixian Hu, Wenli Yang, Shengyun Lin, Lihong Cao, Kongfei Li, Yuemin Kuang, Lihong Shou, Weimei Jin et al. · 2022 · Frontiers in Oncology
  5. Protein–Protein Interactions in Cancer
    Krishna Mohan Poluri, Khushboo Gulati, Deepak Kumar Tripathi, Nupur Nagar · 2023 · Springer eBooks
  6. Dynamics of measurable residual disease for risk stratification and guiding allogeneic transplant in acute myeloid leukaemia patients with myelodysplasia‐related mutations in first remission
    Ling Jiang, Jiaying Cheng, Junya Sun, Yujiao Zhang, Qian Vicky Wu, Yun Huang, Zhiquan Long, Ping Yan, Xuejie Jiang · 2024 · British Journal of Haematology
  7. Promoting spliceosome assembly for therapeutic intent
    Bin Lü, Omar Ibrahim Abdel-Wahab · 2021 · Trends in Pharmacological Sciences
  8. RNA splicing factors in normal hematopoiesis and hematologic malignancies: novel therapeutic targets and strategies
    Zhenzhen Li, Zhongzheng He, Jihan Wang, Guangyao Kong · 2023 · Journal of Leukocyte Biology
  9. SpliceUp: Predicting SF3B1 mutations in individual cells via aberrant splice site activation from scRNA-seq data
    Maksim M. Kholmatov, Karin D. Prummel, Borhane Guezguez, Eva Hellström‐Lindberg, Pedro Luís Moura, Judith B. Zaugg · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  10. Aberrant splicing of MBD1 reshapes the epigenome to drive convergent myeloerythroid defects in MDS
    He Tian Chen, Pratik Joshi, Séverine Cathelin, Soheil Jahangiri, Saeer A Adeel, Joshua Xu, Emily Tsao, Yulin Mo, David Kealy, Adam Dowle et al. · 2026 · Blood
  11. BRD4 and MYB inhibition overcomes venetoclax resistance in EVI1-rearranged acute myeloid leukemia
    Weijia Zang, Yui Koike, Koutarou Nishimura, Atsushi Tanaka, Hiromi Yamazaki, Takaya Yamasaki, Hiromi Ito, Yifan Zhang, Yumi Aoyama, Wataru Saika et al. · 2025 · Scientific Reports
  12. Dysregulation of mRNA splicing in urothelial carcinoma: Clinical, diagnostic and therapeutic implications
    Rod Carlo Columbres, Andrea Borghese Apolo, Abdul Rouf Banday · 2025 · Bladder Cancer
  13. Oncogenic SF3B1 mutations alter the splicing of mRNA noncoding regions to induce a novel therapeutic vulnerability
    Michał Sekrecki, Agata Sekrecka, Rohan Lattupally, Kenny Le, Xiaokang Jin, Chen Mozes, Brendan G. Dwyer, Zhe Zhuang, Bryan A. Romero, Jose Mario Bello Pineda et al. · 2026 · Blood
  14. Harnessing genomics for early cancer detection, risk stratification and prevention
    Muxin Gu, Woody Z Zhang, Rebecca Claire Fitzgerald, Alexander M. Frankell, George S. Vassiliou · 2026 · Nature Genetics
  15. Partial loss of genes might open therapeutic window
    Bo Liu, Omar Ibrahim Abdel-Wahab · 2017 · eLife
  16. Macrocytic anemias
    Mark J. Koury, Daniel J. Hausrath · 2024 · Current Opinion in Hematology
  17. The Development and Use of Scalable Systems for Studying Aberrant Splicing in SF3B1-Mutant CLL
    Tushar Murthy, Kiran Vinod-Paul, Alex C. Minella, Manoj M. Pillai · 2018 · Methods in molecular biology
  18. RETRACTED ARTICLE: Using a new HSPC senescence model in vitro to explore the mechanism of cellular memory in aging HSPCs
    Yongpin Dong, Chunni Guo, Wuxiong Zhou, Wenfang Li, Lina Zhang · 2021 · Stem Cell Research & Therapy · Retracted
  19. The impact of spliceosome mutations in MDS
    Jacqueline Boultwood, Andrea Pellagatti · 2019 · HemaSphere
  20. Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
    Md Rafikul Islam, Preeti Nagar, Naomi McNaughton, Shabiha Afroj Heeamoni, Md Mahbub Hasan, Shila Kandel, Israt Jahan Mukta, Panagiotis Tsakiroglou, William Brian Dalton, Omar Ibrahim Abdel-Wahab et al. · 2026 · Genes & Development
  21. Unraveling the Impact of Aberrant Splicing Machinery on Drug Resistance in Breast Cancer: Identifying Targets for Innovative Counteractive Strategies
    Rodney Hull, Bahoueli Gaudji, David O. Bates, Zodwa Dlamini · 2024 · Springer eBooks
  22. SF3B1K700E mutation in human embryonic stem cells causes aberrant expression of immune-related genes
    Mahtab Dastpak, Claudia A. Mimoso, Moein Farshchian, Christina L. Paraggio, Claudia E. Leonard, Shanye Yin, Binkai Chi, Kelsey W. Nassar, R. Grant Rowe, Jiuchun Zhang et al. · 2025 · PLoS ONE
  23. Recent Advances in Targeting RNA Splicing Factors with Small Molecules
    Xinrui Yuan, Chao‐Yie Yang · 2026 · Journal of Medicinal Chemistry
  24. Splicing modulation as an emerging therapeutic strategy in cancer: molecular mechanisms, clinical development, and future perspectives
    Xinbate Jingele, Qinxinru Sun, Xiaoyang Li, Xinyu Li, Ayana Kon, Xuerui Tao, Akihide Yoshimi · 2026 · Japanese Journal of Clinical Oncology
  25. RNA in cancer
    Maciej Cieśla · 2020 · Elsevier eBooks
  26. Physiopathologie des syndromes myélodysplasiques
    Michaëla Fontenay, Ismaël Boussaid, Nicolas Chapuis · 2023 · Bulletin du Cancer
  27. Omics wise analysis of RNA splicing
    Alexander Modestov, Anton A. Buzdin, Vladimir Prassolov · 2025 · Elsevier eBooks
  28. Oncogenic Landscapes of Splicing-Factor Mutant MDS
    Mohammad Alinoor Rahman · 2018 · Genomics & Gene Therapy International Journal
  29. RNA Splicing: Basic Aspects Underlie Antitumor Targeting
    Alzahraa Fergany, Victor Vyacheslavovich Tatarskiy · 2020 · Recent Patents on Anti-Cancer Drug Discovery
  30. CRISPR editing of sftb-1 /SF3B1 in C. elegans allows the identification of synthetic interactions with cancer-related mutations and the chemical inhibition of splicing
    Xènia Serrat, Dmytro Kukhtar, Eric Cornes, Anna Esteve‐Codina, Helena Benlloch, Germano Cecere, Julián Cerón · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  31. The minor spliceosome offers a therapeutically viable target for the treatment of a broad spectrum of cancers
    Karen Doggett, Kimberly J Morgan, Stephen Mieruszynski, Benjamin B Williams, Anouk M. Olthof, Alexandra L. Garnham, Michael J. G. Milevskiy, Lachlan W. Whitehead, Janine L. Coates, Michael Büchert et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  32. Spliceosome Inhibition in SF3B1 -Mutated Uveal Melanoma
    Josephine Q.N. Nguyen, Wojtek Drabarek, Aïsha M. C. H. J. Leeflang, Tom Brands, Thierry P. P. van den Bosch, Robert M. Verdijk, Harmen J.G. van de Werken, Job van Riet, Dion A. Paridaens, Annelies de Klein et al. · 2022 · medRxiv
  33. Integrative CRISPR Screens and RNA-Omics Discover an Essential Role for PUF60-3’ Splice Site Interactions in Cancer Progression
    Alexandra T. Tankka, Jaclyn M. Einstein, Catherine J. Zhou, Vivian N. Pham, Yuhan Zhang, Jack T. Naritomi, Grady G. Nguyen, Orel Mizrahi, Mark Perelis, Joseph Sarsam et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  34. CDK8 is a critical effector of cell fate dysregulation in SF3B1 -mutant MDS
    Elizabeth A. Bonner, Tun‐Yun Hsueh, Axia Song, Laura Baquero Galvis, Erica A. Arriaga-Gomez, Rasika Venkataraman, Sayantani Sinha, Evan Nguyen, Paul Brent Ferrell, Robert S. Welner et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  35. BCLAF1 links RNA splicing to ATF4-dependent metabolic adaptation in acute myeloid leukemia
    Laura López-Hernández, Stephanie J. Crowley, Sara Cea-Sánchez, Ricardo de Arellano, Neetij Krishnan, Patrick Toolan-Kerr, Lynn S. White, Domenico Ignoti, Emily Soto-Hidalgo, Stefano Gustincich et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  36. RNA splicing factor mutations drive myeloid neoplasm oncogenesis through protein complex poisoning
    Pedro Luís Moura, Rui Mamede Branca, Yaroslav Kaminskiy, Ioannis Siavelis, Kovi R Shrung, Sophia Hofmann, Christina Maria Perraki, Alexandra Argyriou, Sadaf Fazeli, Masahiro M Nakagawa et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  37. Leukemic Stem Cells S(p)liced Off
    Margarida Ferreira-Teixeira, Britta Will · 2016 · Cell stem cell
  38. From the bedside to the bench: new discoveries on blood cell fate and function
    Eirini Trompouki, Eugenia Flores Figueroa, Daniel Lucas, Teresa Venezia Bowman · 2016 · Experimental Hematology
  39. Mutant P53 in pre-leukemic hematopoietic stem cells and the pathogenesis of Myelodysplastic Syndrome
    Sisi Chen · 2018 · IUScholarWorks (Indiana University)
  40. Impaired hematopoiesis and leukemia development in mice with a conditional “knock-in” allele of a mutant splicing factor gene U2af1
    Dennis Liang Fei, Tao Zhen, Benjamin Durham, John Ferrarone, Tuo Zhang, Lisa Garrett, Akihide Yoshimi, Omar Abdel-Wahab, Robert K. Bradley, Paul Liu et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  41. Proteomics Exploration of Chronic Lymphocytic Leukemia
    Ti’ara L. Griffen · 2019 · Novel Approaches in Cancer Study
  42. Modelling Ineffective Erythropoiesis in Myelodysplastic Syndromes with Ring Sideroblasts
    Edda María Elvarsdóttir · 2019 · Figshare
  43. Analyzing Co-transcriptional Processing by Nanopore Sequencing
    Heather L. Drexler · 2019 · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
  44. [Clonal evolution of myelodysplastic syndrome].
    Bingqing Luo, Fang Dong, Hideo Ema · 2019 · PubMed Central
  45. Mutations in the Spliceosomal Gene ZRSR2 in Myelodysplastic Syndromes
    Harold Phillip Koeffler · 2019
  46. Chemokine Receptor 1 and its associated immune pathway are downregulated in SF3B1 MT blood and non-blood cancers
    Mahtab Dastpak, Hyunmin Kim, Christina L. Paraggio, Claudia E. Leonard, Shanye Yin, Binkai Chi, Kelsey W. Nassar, R. Grant Rowe, Zhonggang Hou, Jiuchun Zhang et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  47. Alternative Splicing of Pre-messenger RNA
    Vanessa Cristina Arfelli, Leticia Fröhlich Archangelo · 2022 · Springer eBooks
  48. Faculty Opinions recommendation of U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies.
    Stephen D. Nimer, Glòria Mas Martín · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  49. Molecular Threat of Splicing Factor Mutations to Myeloid Malignancies and Potential Therapeutic Modulations
    Fangliang Zhang, Liang Chen · 2022 · Biomedicines
  50. Data from Nonsense-Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells Harboring SF3B1 or U2AF1 Mutations
    Abigael Cheruiyot, Shan Li, Sridhar Nonavinkere Srivatsan, Tanzir Ahmed, Yuhao Chen, Delphine Sangotokun Lemacon, Ying Li, Zheng Yang, Brian A. Wadugu, Wayne A. Warner et al. · 2023
  51. Data from Nonsense-Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells Harboring SF3B1 or U2AF1 Mutations
    Abigael Cheruiyot, Shan Li, Sridhar Nonavinkere Srivatsan, Tanzir Ahmed, Yuhao Chen, Delphine Sangotokun Lemacon, Ying Li, Zheng Yang, Brian A. Wadugu, Wayne A. Warner et al. · 2023
  52. Molecular testing in myelodysplastic syndromes
    Noah A. Brown, Bryan L. Betz · 2023 · Elsevier eBooks
  53. Research Progress on the Role of Variable Splicing in Ovarian Cancer
    黔川 冉 · 2024 · Advances in Clinical Medicine
  54. SF3B1 -mutant mis-splicing of UBA1 confers a targetable therapeutic vulnerability through UBA1 inhibition
    Jonas Thier, Sophia Hofmann, Katharina Miria Kirchhof, Gabriele Todisco, Teresa Mortera Blanco, Indira Barbosa, Ann-Charlotte Björklund, André G. Deslauriers, Elli Papaemmanuil, Eirini P. Papapetrou et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  55. SUGP1 loss is the sole driver of SF3B1 hotspot mutant missplicing in cancer
    Peiqi Xing, Pedro Bak‐Gordon, Jindou Xie, Jian Zhang, Zhaoqi Liu, James L. Manley · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  56. Splicing factor 3b subunit 1 mutation patterns and prognostic implications in myelodysplastic syndromes, acute myeloid leukemia, and chronic lymphocytic leukemia: A retrospective study of 1691 cases
    Chun Qiao, Yi Xia, Zhen Guo, Lìyǐng Zhū, Yujie Wu, Hai-rong Qiu, Yan Wang, Huayuan Zhu, Sixuan Qian, Ming Hong et al. · 2025 · Cancer
  57. Transcriptional patterns of cancer-related genes in primary and metastatic tumours revealed by machine learning
    Faeze Keshavarz-Rahaghi, E. Pleasance, S. Jones · 2025 · BMC Biology
  58. Additional file 1 of Using a new HSPC senescence model in vitro to explore the mechanism of cellular memory in aging HSPCs
    Yongpin Dong, Guo, Chunni, Wuxiong Zhou, Li, Wenfang, Zhang, Lina · 2021 · Figshare
  59. Additional file 1 of SF3B1 inhibition disrupts malignancy and prolongs survival in glioblastoma patients through BCL2L1 splicing and mTOR/ß-catenin pathways imbalances
    Fuentes-Fayos, Antonio C., Jesús M. Pérez‐Gómez, Miguel E. G-García, Jiménez-Vacas, Juan M., Cristóbal Blanco-Acevedo, Rafael Sánchez‐Sánchez, Juan Solivera, Joshua J. Breunig, Gahete, Manuel D., Castaño, Justo P. et al. · 2022 · Figshare
  60. Additional file 3 of Using a new HSPC senescence model in vitro to explore the mechanism of cellular memory in aging HSPCs
    Yongpin Dong, Guo, Chunni, Wuxiong Zhou, Li, Wenfang, Zhang, Lina · 2021 · Figshare
  61. Additional file 2 of Using a new HSPC senescence model in vitro to explore the mechanism of cellular memory in aging HSPCs
    Yongpin Dong, Guo, Chunni, Wuxiong Zhou, Li, Wenfang, Zhang, Lina · 2021 · Figshare
  62. Additional file 4 of Using a new HSPC senescence model in vitro to explore the mechanism of cellular memory in aging HSPCs
    Yongpin Dong, Guo, Chunni, Wuxiong Zhou, Li, Wenfang, Zhang, Lina · 2021 · Figshare
  63. SF3B1 K700E rewires splicing of cell cycle regulators
    Mai Baker, Eden Engal, Aveksha Sharma, Mayra Petasny, Shiri Jaffe‐Herman, Ophir Geminder, Minhua Su, Mercedes Bentata, Adi Gershon, Gillian Kay et al. · 2025 · RNA
  64. Clonal hematopoiesis is associated with future diseases and mortality
    Weishi Liu, Yueting Deng, Liu Yang, Ziyi Wang, Lingzhi Ma, Yuming Xu, Qiang Dong, Jianfeng Feng, Wei Cheng, Jintai Yu · 2025 · Chinese Medical Journal
  65. The SF3B1 inhibitor pladienolide B massively inhibits DNA damage signaling and repair and counteracts resistance to platinum salts in Non-Small Cell Lung Cancer
    Nour Jamal-El-Hussein, Shipra Chaudhary, Élodie Montaudon, Fariba Némati, Aurélie Genoux, Hélène Polvèche, Rania El Botty, Caroline Barette, Tao Jia, Didier Auboeuf et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  66. Dérégulations neuro-développementales impliquées dans les malformations du développement cortical associées aux mutations du gène KIF2A : apport d'un modèle murin knock-in conditionnel
    Johan Gilet · 2019 · theses.fr (ABES)
  67. Stage-specific changes in the Krebs cycle network regulate human erythroid differentiation
    Manuela Romano · 2018 · theses.fr (ABES)
  68. UHM-ULM interactions in spliceosomal complexes : structural characterization and targeting with small molecules
    Asaki Kobayashi · 2020
  69. Role of SF3B1 Mutations in Uveal Melanoma Oncogenesis
    Raquel Vivet-Noguer · 2021 · theses.fr (ABES)
  70. Identifier et exploiter de nouvelles vulnérabilités à potentiel thérapeutique dans les leucémies aiguës myéloïdes
    Camille Vaganay · 2023
  71. Études de l’impact des anomalies génétiques dans l’initiation, l’évolution et la résistance au traitement dans la leucémie lymphoïde chronique : exemple de la mutation d’IKZF3 p.L162R et des anomalies de TP53
    Grégory Lazarian · 2020
  72. Étude de la restauration de la réponse immunitaire antitumorale dans un modèle murin de cancer pulmonaire induit par une molécule multicible inhibitrice de HDAC et du splicéosome
    Sarah Ducellier · 2023
  73. Inflammatory Signatures in MDS: The Missing Link Between Genetics, Microenvironment, and Therapy
    Adele Bottaro, Maria Elisa Nasso, Giuseppe Mirabile, Manlio Fazio, Alessandro Allegra · 2026 · Cells
  74. Inhibition of RNA splicing is a novel therapeutic strategy for disruption of nuclear replicating viruses
    Lorenzo Serra, Claire M O'Brien, Molly R. Patterson, Clayton J. Otter, Alison Yu, Reyes Acosta, Daniel T. Claiborne, Susan Reich Weiss, Alexander M. Price · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  75. Splicing Factor Mutations in Clonal Hematopoiesis and Progression to Myeloid Neoplasms
    Yang Lyu, Yutong Zhang, Ayana Kon · 2026 · Cancer Science
  76. PANoptosis in the pathogenesis of myelodysplastic syndromes
    Rohit Thalla, Jyoti Lamichhane, Cameron Lewis, Peter Breslin, Jiwang Zhang · 2026 · Molecular Oncology
  77. CRISPR-mediated Correction of Oncogenic AS-NMD in Splicing Factor Mutant Cancer
    Preeti Nagar, Md Rafikul Islam, Nirjhor Anuvob Rahman, Shabiha Afroj Heeamoni, Md Mahbub Hasan, Saaimatul Huq, Rezwan Ali, Mokarram Hossain, Mohammad Alinoor Rahman · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  78. RNA splicing in health and disease
    Huining Huang, Yao Yu, Qian Zhou, Guangtong Deng, Yayun Li, Furong Zeng · 2026 · Molecular Biomedicine
  79. The splicing axis of aging: mechanisms and therapeutic opportunities
    Sada Raza, Ankita Kumari, Maciej Cieśla · 2026 · Trends in Molecular Medicine
  80. CRISPR-mediated correction of oncogenic AS-NMD in splicing factor mutant cancer
    Preeti Nagar, Md Rafikul Islam, Nirjhor Anuvob Rahman, Shabiha Afroj Heeamoni, Md Mahbub Hasan, Saaimatul Huq, Fariha Alam Bushra, Mengye Hu, Rezwan Ali, Mokarram Hossain et al. · 2026 · Frontiers in Immunology